Piperazine- and Piperidine-Containing Thiazolo[5,4-<i>d</i>]pyrimidine Derivatives as New Potent and Selective Adenosine A_2A Receptor Inverse Agonists

Documenti analoghi

• Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A₁ and A_2A Receptors, and Efficacy in Animal Models of Depression
  di: Flavia Varano, et al.
  Pubblicazione: (2021-07-01)
• A_2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease
  di: Stefania Gessi, et al.
  Pubblicazione: (2021-09-01)
• The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles
  di: Lucia Squarcialupi, et al.
  Pubblicazione: (2017-01-01)
• A₃ Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
  di: Andrea Spinaci, et al.
  Pubblicazione: (2022-01-01)
• How Are Adenosine and Adenosine A_2A Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?
  di: Akihisa Mori, et al.
  Pubblicazione: (2021-08-01)